In Avanir Pharmaceuticals Inc (NASDAQ:AVNR)’s Rejected Drug Device, Analysts Hold A Different View

Boston, MA 11/27/2014 (wallstreetpr) – Avanir Pharmaceuticals Inc (NASDAQ:AVNR) suffered a blow this week when the U.S. Food and Drug Administration declined to approve its migraine drug device. The company had sought marketing approval for the device, which in many ways has good revenue promise. However, even though the FDA rejected the device, analysts believe that […]

Avanir Pharmaceuticals Inc (NASDAQ:AVNR) To Raise $200 Million From Public Share Offering

Boston, MA 09/24/2014 (wallstreetpr) – Pharmaceutical company, Avanir Pharmaceuticals Inc (NASDAQ:AVNR) said that it would be raising a little over $200 million from the issue of fresh shares to the general public. It would use the funds for general corporate purposes. The issue announcement comes on the heels of the company announcing favorable Phase II […]

Investors Lured By Avanir Pharmaceuticals Inc (NASDAQ:AVNR), As Its AVP-923 Trial Turns Out Successful

Boston, MA 09/16/2014 (wallstreetpr) – The stock of Avanir Pharmaceuticals Inc (NASDAQ:AVNR) is on the soaring spree. At the end of day’s trade on September 15, AVNR gained a whopping 5.75, i.e. around 85.31% of its net per unit dollar value. The organization notched up positive Phase II results pertaining to its renowned drug – […]

You May Want To Compare: Avanir Pharmaceuticals (AVNR), Peabody Energy (BTU), Zogenix, Inc. (ZGNX), JetBlue Airways (JBLU)

Boston, MA 08/27/2014 (wallstreetpr) – Avanir Pharmaceuticals Inc (NASDAQ:AVNR) announced the enrollment of the first patient for the Phase II study of its major depressive disorder (MDD) treatment. It said the Phase II study of the drug called AVP-786 will focus on evaluating the efficacy, tolerability and safety of the treatment. There are millions of […]

Avanir Pharmaceuticals Inc (NASDAQ:AVNR): Lot Of Action At The Avanir Front

Boston, MA 05/02/2014 (wallstreetpr) – One of the leading players in the pharmaceutical business, Avanir Pharmaceuticals Inc (NASDAQ:AVNR) operates towards development  of therapeutic products in the field of treatment of CNS disorders. Recently many actions have taken place in the Avanir’s front including series of announcements and lawsuits. The company is marking up towards development of […]

Cardiome Pharma Corporation (NASDAQ:CRME) Stock Moves Higher; Performance Better Than Some Competitors

Boston, MA 03/06/2014 (wallstreetpr) – Cardiome Pharma Corporation (NASDAQ:CRME) stock surged higher by 27% in the last four weeks. The stock is performing better than its 20 day Simple Moving Average. While analysts at Zacks see the trend as a good one and expect investors to be happy with the company’s short term performance, they […]

Avanir Pharmaceuticals Inc. (NASDAQ:AVNR) has Accelerated Pathway for New Drug

Boston, MA 06/06/2013 (wallstreetpr) – The shares of Avanir Pharmaceuticals Inc. (NASDAQ:AVNR) had surged by 13.06 percent to close at $3.81 per share for the end of last trading session on Wednesday. The shares of the company had been trading in the range of $3.49 to $3.84 per share during the day. The shares of Avanir […]